If you could vote on Brexit now which option would you choose?
   

COVAX Obstacles and Shortages Threaten Africa's Coronavirus Vaccine Rollout


Africa has lagged behind in the race to acquire coronavirus vaccines since it began. It was clear individual governments would not be able to compete against wealthier nations purchasing limited stocks, so a collective effort quickly got underway. When the first doses arrived in Ghana, the Ivory Coast, Kenya, and Rwanda in late February and early March, it seemed like the continent’s rollout had finally gotten off the ground. However, efforts are stumbling in the face of systemic obstacles to distribution. Now, India’s surging third wave could also directly affect the continent’s access to vaccines. Africa has gotten most of its vaccine doses through the COVID-19 Vaccines Global Access (COVAX) initiative, backed by the World Health Organization, the European Commission, and Gavi, the Vaccine Alliance, which pools donor funding to allow developing countries to acquire shots—primarily AstraZeneca, which doesn’t require below-freezing storage. COVAX now needs an additional $2 billion to continue its work.

Foreign Policy - April 21, 2021

View the full story here: https://foreignpolicy.com/2021/04/21/covax-africa-vaccine-rollout-coronavirus-pandemic/